Podcasts about GU

Australia has a dark chapter of history that many are still learning about. Following European settlement, Aboriginal and Torres Strait Islander children were removed from their families and forced into non-Indigenous society. The trauma and abuse they experienced left deep scars, and the pain still echoes through the generations. But communities are creating positive change. Today these people are recognised as survivors of the Stolen Generations. - Australia aleŋ anyiköl alɔŋ cool ŋuɔ̈t piöc kɔc kɔ̈k bïk ŋic. Buɔ̈th bɛn kɔc tuëŋ European ci ke ciök riëk piny, mith Aboriginal and Torres Strait Islander aci nyiäi kääcken cïn ku thɛ̈ɛ̈ny kek muök kɔc cie-Aboriginal akutnhom dɛt. Guöm ku yioŋyiöŋ ci reet ke nhiim aci keek nyiäŋ ke piɛ̈ɛ̈r ke guop, ku arɛɛm a ŋuɔt latuëŋ riëëny kith yiic. mɛ̈n wuönken aci ke pɛth looi bïk näŋ ke pɛɛth waar kë. Yekölë, kɔc käk aŋic kek ke piir ke ye kɔc e rïïny cï kuäl wei.

Öll viðtölin úr þætti dagsins ásamt símatíma: Elín Guðný Hlöðversdóttir, eigandi Litlu kaffistofunnar sem lokar á morgun Magnús Hlynur Hreiðarsson fréttamaður á Sýn Þórunn Sveinbjarnardóttir, forseti Alþingis um framhald þingstarfa, sumarfrí, málþóf og málin sem bíða Halla Björk Reynisdóttir forseti bæjarstjórnar Akureyrar Simatími Leó Árnason prímusmótor í uppbyggingu Miðbæjarins á Selfossi Rúna Ásmundsdóttir vegagerðinni um hjartaljósin á Akureyri Jóhannes Þór Skúlason, framkvæmdastjóri Samtaka ferðaþjónustunnar Ragnar Freyr Yngvarsson formaður læknafélags Reykjavíkur Bragi Bjarnason, bæjarstjóri Árborgar

Samfélagið sendi út frá hljóðveri Ríkisútvarpsins í Hjálmakletti í Borgarnesi og ræddi við forsvarsmenn hátíðanna tveggja sem setja svip sinn á bæinn um helgina, Hinseginhátíð Vesturlands og Brákarhátíð. Við skoðum úrvalið í Regnbogasjoppunni og Guðrún Steinunn Guðbrandsdóttir, forseti Hinsegin Vesturlands, og Hafþór Ingi Gunnarsson, formaður Hollvinasamtaka Borgarness, segja frá tilurð hátíðanna, mikilvægi þeirra fyrir samfélagið og helstu dagskrárliðum. Heiðrún Helga Bjarnadóttir, sóknarprestur í Borgarnesi, ræðir síðan um regnbogamessur, fræðslustarf kirkjunnar og mikilvægi þess að kirkjan og öll þau sem hafa rödd og vettvang til að láta í sér heyra standi með hinsegin samfélaginu. Tónlist í þættinum: HJÁLMAR - Áttu vinur augnablik. Franklin, Aretha - The masquerade is over. Bill Withers - Lean On Me. STJÓRNIN - Hleypum gleðinni inn. ARETHA FRANKLIN - I Say A Little Prayer.

Ljúfur föstudagur. Jóna og Hafdís frá Kátt á Vífilstaðatúni sögðu frá hátíðarhöldum helgarinnar og póstkort bárust frá hljómsveitinni Skátum og Karli Örvarssyni. NÝDÖNSK - Alelda. Selma Björnsdóttir - All Out Of Luck. Halli og Laddi - Gibba gibb. Bee Gees - Stayin' Alive. FM Belfast - Synthia. Æfing Hljómsveit - Fínn karl kerlingin hans. Inspector Spacetime - Dansa og Bánsa. ARON CAN - Aldrei heim. EIRÍKUR HAUKSSON - Gaggó Vest (Í Minningunni). Ágúst Þór Brynjarsson - Á leiðinni. ELÍN EY & PÉTUR BEN - Þjóðvegurinn. Blanco, Benny, Gomez, Selena - Talk. YAZOO - Only You. Ágúst Elí Ásgeirsson - Megakjut. SHAKIRA - Whenever, wherever. BRAINSTORM - My Star. KIM LARSEN - Papirsklip. BLAZROCA OG ÁSGEIR TRAUSTI - Hvítir skór. Mammaðín - Frekjukast. THE JAM - Town Called Malice. Stebbi JAK - Djöflar. BRANDY - The boy is mine. Arney Ingibjörg Sigurbjörnsdóttir, Sigurbjörn Daði Dagbjartsson - Hamingjusöm á ný. Clayton, Adam, Mullen, Larry - Impossible : Theme from Mission. Geislar - Solifaction. FRATELLIS - Chelsea Dagger. Jóhanna Guðrún Jónsdóttir Söngkona - Þú ert nú meiri. STUÐMENN - Ástardúett. THE BEATLES - All You Need Is Love. SIGURÐUR GUÐMUNDSSON & MEMFISMAFÍAN - Síðasti móhítóinn. Bríet - Blood On My Lips. MUSE - Supermassive Black Hole (MP3). Kaleo - Bloodline. HJÁLMAR - Taktu þessa trommu. Skátar - Halldór Ásgrímsson (2025 Master). Daði Freyr Pétursson - I don't wanna talk. Dion, Céline - That's the way it is. Minogue, Kylie, Williams, Robbie, Williams, Robbie - Kids. CHRISTINE AND THE QUEENS - Tilted. Moses Hightower - Bílalest út úr bænum. DESTINY´S CHILD - Say My Name.

Aujourd'hui, je vous propose un épisode spécial burnout du podcast Pourquoi pas moi.J'ai eu la chance d'interviewer le Dr Marine Crest, médecin généraliste, psychologue, spécialiste du microbiote… et surtout profondément engagée sur le sujet du burn-out. Marine parle en connaissance de cause : elle a elle-même traversé cette épreuve.Cet échange précieux a été initialement offert en exclusivité aux membres de mon programme "Rebondir après un burnout", et nous avons décidé, avec Marine, de le rendre accessible à toutes et tous.Dans cet épisode, elle nous éclaire avec bienveillance et expertise sur :ce qui peut mener à un burn-out,quand et comment se remettre en mouvement,quoi faire dès les premières semaines d'arrêt,comment l'entourage peut soutenir au mieux,les outils pour éviter la rechute,et bien plus encore.Elle nous parle aussi de son association Guérir en mer, née de son propre parcours. Que tu sois en plein burn-out, ou simplement concerné.e de près ou de loin, cet épisode est une mine d'or.

Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss important advances in the treatment of prostate, bladder, and kidney cancers that were presented at the 2025 ASCO Annual Meeting. TRANSCRIPT Dr. Neeraj Agarwal: Hello, and welcome to the ASCO Daily News Podcast. I am Dr. Neeraj Agarwal, your guest host of the ASCO Daily News Podcast today. I am the director of the Genitourinary Oncology Program and a professor of medicine at the University of Utah Huntsman Cancer Institute and editor-in-chief of the ASCO Daily News.  I am delighted to be joined by Dr. Jeanny Aragon-Ching, a GU medical oncologist and the clinical program director of the GU Center at the Inova Schar Cancer Institute in Virginia. Today, we will be discussing some key abstracts in GU oncology that were presented at the 2025 ASCO Annual Meeting.  Our full disclosures are available in the transcript of this episode.  Jeanny, it is great to have you on the podcast. Dr. Jeanny Aragon-Ching: Oh, thank you so much, Neeraj. Dr. Neeraj Agarwal: Jeanny, let's begin with some prostate cancer abstracts. Let's begin with Abstract 5017 titled, “Phase 1 study results of JNJ-78278343 (pasritamig) in metastatic castration-resistant prostate cancer.” Can you walk us through the design and the key findings of this first-in-human trial? Dr. Jeanny Aragon-Ching: Yeah, absolutely, Neeraj. So this study, presented by Dr. Capucine Baldini, introduces pasritamig, a first-in-class T-cell redirecting bispecific antibody that simultaneously binds KLK2 on prostate cancer cells and CD3 receptor complexes on T cells. KLK2 is also known as human kallikrein 2, which is selectively expressed in prostate tissue. And for reference, KLK3 is what we now know as the PSA, prostate-specific antigen, therefore making it an attractive and specific target for therapeutic engagement. Now, while this was an early, first-in-human, phase 1 study, it enrolled 174 heavily pretreated metastatic CRPC patients. So many were previously treated with ARPIs, taxanes, and radioligand therapy. So given the phase 1 nature of this study, the primary objective was to determine the safety and the RP2D, which is the recommended phase 2 dose. Secondary objectives included preliminary assessment of antitumor activity. So, pasritamig was generally well tolerated. There were no treatment-related deaths. Serious adverse events were rare. And in the RP2D safety cohort, where patients received the step-up dosing up to 300 mg of IV every 6 weeks, the most common treatment-related adverse events were low-grade infusion reactions. There was fatigue and grade 1 cytokine release syndrome, what we call CRS. And no cases of neurotoxicity, or what we call ICANS, the immune effector cell-associated neurotoxicity syndrome, reported. Importantly, the CRS occurred in just about 8.9% of patients. All were grade 1. No patients required tocilizumab or discontinued treatment due to adverse events. So, this suggests a favorable safety profile, allowing hopefully for outpatient administration without hospitalization, which will be very important when we're thinking about bispecifics moving forward. In terms of efficacy, pasritamig showed promising activity. About 42.4% of evaluable patients achieved a PSA50 response. Radiographic PFS was about 6.8 months. And among patients with measurable disease, the objective response rate was about 16.1% in those with lymph node or bone metastases, and about 3.7% in those with visceral disease, with a median duration of response of about 11.3 months. So, altogether, this data suggests that pasritamig may offer a well-tolerated and active new potential option for patients with metastatic CRPC.   Again, as a reminder, with the caveat that this is still an early phase 1 study. Dr. Neeraj Agarwal: Thank you, Jeanny. These are promising results for a bispecific T-cell engager, pasritamig, in prostate cancer. I agree, the safety and durability observed here stand out, and this opens the door for further development, possibly even in earlier disease settings.  So, shifting now from immunotherapy to the evolving role of genomics in prostate cancer. So let's discuss Abstract 5094, a real-world, retrospective analysis exploring the prognostic impact of homologous recombination repair gene mutations, especially BRCA1 and BRCA2 mutations, in metastatic hormone-sensitive prostate cancer. Can you tell us more about this abstract, Jeanny? Dr. Jeanny Aragon-Ching: Sure, Neeraj. So this study was presented by Dr. David Olmos, represents one of the largest real-world analyses we have evaluating the impact of homologous recombination repair, or what we would call HRR, alterations in metastatic hormone-sensitive prostate cancer. So, this cohort included 556 men who underwent paired germline and somatic testing. Now, about 30% of patients had HRR alterations, with about 12% harboring BRCA1 or BRCA2 mutations and 16% having alterations in other HRR genes. Importantly, patients were stratified via CHAARTED disease volume, and outcomes were examined across treatment approaches, including ADT alone, doublet therapy, and triplet therapy. The prevalence of BRCA and HRR alterations were about similar between the metastatic hormone-sensitive prostate cancer and the metastatic castrate-resistant prostate cancer, with no differences observed, actually, between the patients with high volume versus low volume disease.  So, the key finding was that BRCA and HRR alterations were associated with poor clinical outcomes in metastatic hormone-sensitive prostate cancer. And notably, the impact of these alterations may actually be even greater in metastatic hormone-sensitive prostate cancer than previously reported in metastatic CRPC. So, the data showed that when BRCA mutations are present, the impact of the volume of disease is actually limited. So, poor outcomes were observed across the board for both high-volume and low-volume groups. So, the analysis showed that patients with HRR alterations had significantly worse outcomes compared to patients without HRR alterations. Median radiographic progression-free survival was about 20.5 months for the HRR-altered patients versus 30.6 months for the non-HRR patients, with a hazard ratio of 1.6. Median overall survival was 39 months for HRR-altered patients compared to 55.7 months for the non-HRR patients, with a hazard ratio of 1.5. Similar significant differences were observed when BRCA-mutant patients were compared with patients harboring non-BRCA HRR mutations. Overall, poor outcomes were independent of treatment of ARPI or taxanes. Dr. Neeraj Agarwal: Thank you, Jeanny. So, these data reinforce homologous recombination repair mutations as both a predictive and prognostic biomarker, not only in the mCRPC, but also in the metastatic hormone-sensitive setting as well. It also makes a strong case for incorporating genomic testing early in the disease course and not waiting until our patients have castration-resistant disease. Dr. Jeanny Aragon-Ching: Absolutely, Neeraj. And I think this really brings home the point and the lead up to the AMPLITUDE trial, which is LBA5006, a phase 3 trial that builds on this very concept of testing with a PARP inhibitor, niraparib, in the hormone-sensitive space. Can you tell us a little bit more about this abstract, Neeraj? Dr. Neeraj Agarwal: Sure. So, the AMPLITUDE trial, a phase 3 trial presented by Dr. Gerhardt Attard, enrolled 696 patients with metastatic hormone-sensitive prostate cancer and HRR gene alterations. 56% of these patients had BRCA1 and BRCA2 mutations. Patients were randomized to receive abiraterone with or without niraparib, a PARP inhibitor. The majority of patients, 78% of these patients, had high-volume metastatic hormone-sensitive prostate cancer, and 87% of these patients had de novo metastatic HSPC. And 16% of these patients received prior docetaxel, which was allowed in the clinical trial. So, with a median follow-up of nearly 31 months, radiographic progression-free survival was significantly prolonged with the niraparib plus abiraterone combination, and median was not reached in this arm, compared to abiraterone alone, which was 29.5 months, with a hazard ratio of 0.63, translating to a 37% reduction in risk of progression or death. This benefit was even more pronounced in the BRCA1 and BRCA2 subgroup, with a 48% reduction in risk of progression, with a hazard ratio of 0.52. Time to symptomatic progression also improved significantly across all patients, including patients with BRCA1, BRCA2, and HRR mutations. Although overall survival data remain immature, early trends favored the niraparib plus abiraterone combination. The safety profile was consistent with prior PARP inhibitor studies, with grade 3 or higher anemia and hypertension were more common but manageable. Treatment discontinuation due to adverse events remained low at 11%, suggesting that timely dose modifications when our patients experience grade 3 side effects may allow our patients to continue treatment without discontinuation. These findings support niraparib plus abiraterone as a potential new standard of care in our patients with metastatic hormone-sensitive prostate cancer with HRR alterations, and especially in those who had BRCA1 and BRCA2 mutations. Dr. Jeanny Aragon-Ching: Thank you, Neeraj. This trial is especially exciting because it brings PARP inhibitors earlier into the treatment paradigm. Dr. Neeraj Agarwal: Exactly. And it is exciting to see the effect of PARP inhibitors in the earlier setting.  So Jeanny, now let's switch gears a bit to bladder cancer, which also saw several impactful studies. Could you tell us about Abstract 4502, an exploratory analysis from the EV-302 trial, which led to approval of enfortumab vedotin plus pembrolizumab for our patients with newly diagnosed metastatic bladder cancer? So here, the authors looked at the outcomes in patients who achieved a confirmed complete response with EV plus pembrolizumab. Dr. Jeanny Aragon-Ching: Sure, Neeraj. So, EV-302 demonstrated significant improvements in progression-free and overall survival for patients previously treated locally advanced or metastatic urothelial cancer, I'll just call it metastatic UC, as a frontline strategy, establishing EV, which is enfortumab vedotin, plus pembro, with pembrolizumab as standard of care in this setting.  So, this year at ASCO, Dr Shilpa Gupta presented this exploratory responder analysis from the phase 3 EV-302 trial. Among 886 randomized patients, about 30.4% of patients, this is about 133, in the EV+P arm, and 14.5% of the patients in the chemotherapy arm, achieved a confirmed complete response. They call it the CCR rates. So for patients who achieved this, median PFS was not reached with EV+P compared to 26.9 months with chemotherapy, with a hazard ratio of 0.36, translating to a 64% reduction in the risk of progression. Overall survival was also improved. So the median OS was not reached in either arm, but the hazard ratio favored the EV+P at 0.37, translating to a 63% reduction in the risk of death. The median duration of complete response was not reached with EV+P compared to 15.2 months with chemotherapy. And among those patients who had confirmed CRs at 24 months, 78% of patients with the EV+P arm remained progression-free, and around 95% of the patients were alive, compared to 54% of patients who were progression-free and 86% alive of the patients in the chemotherapy arm. Safety among responders were also consistent with prior reports. Grade 3 or higher treatment-related adverse events occurred in 62% of EV+P responders and 72% of chemotherapy responders. Most adverse events were managed with dose modifications, and importantly, no treatment-related deaths were reported among those who were able to achieve complete response.  So these findings further reinforce EV and pembro as the preferred first-line therapy for metastatic urothelial carcinoma, offering a higher likelihood of deep, durable responses with a fairly manageable safety profile. Dr. Neeraj Agarwal: Thank you for the great summary, Jeanny. These findings underscore the depth and durability of responses achievable with this combination and also suggest that achieving a response may be a surrogate for long-term benefit in patients with metastatic urothelial carcinoma.  So now, let's move to Abstract 4503, an exploratory ctDNA analysis from the NIAGARA trial, which evaluated perioperative durvalumab, an immune checkpoint inhibitor, in muscle-invasive bladder cancer. So what can you tell us about this abstract? Dr. Jeanny Aragon-Ching: Absolutely, Neeraj. So, in NIAGARA, presented by Dr. Tom Powles, the addition of perioperative durvalumab to neoadjuvant chemotherapy, gem/cis, significantly improved event-free survival, overall survival, and pathologic complete response in patients with cisplatin-eligible muscle-invasive bladder cancer. Recall that this led to the U.S. FDA approval of this treatment regimen on March 28, 2025.  So, a planned exploratory analysis evaluated the ctDNA dynamics and their association with clinical outcomes, which was the one presented recently at ASCO. So, the study found that the incidence of finding ctDNA positivity in these patients was about 57%. Following neoadjuvant treatment, this dropped to about 22%, with ctDNA clearance being more common in the durvalumab arm, about 41%, compared to the chemotherapy control arm of 31%. Notably, 97% of patients who remained ctDNA positive prior to surgery failed to achieve a pathologic CR. So, this indicates a strong association between ctDNA persistence and lack of tumor eradication. So, postoperatively, only about 9% of patients were ctDNA positive. So, importantly, durvalumab conferred an event-free survival benefit regardless of ctDNA status at both baseline and post-surgery. Among patients who were ctDNA positive at baseline, durvalumab led to a hazard ratio of 0.73 for EFS. So, this translates to a 27% reduction in the risk of disease recurrence, progression, or death compared to the control arm. In the post-surgical ctDNA-positive group, the disease-free survival was also improved with a hazard ratio of 0.49, translating to a 51% reduction in the risk of recurrence.  So, these findings underscore the prognostic value of ctDNA and suggest that durvalumab provides clinical benefit irrespective of molecular residual disease status. So, the data also supports that ctDNA is a promising biomarker for future personalized strategies in the perioperative treatment of muscle-invasive bladder cancer. Dr. Neeraj Agarwal: Thank you, Jeanny. It is great to see that durvalumab is improving outcomes in these patients regardless of ctDNA status. However, based on these data, presence of ctDNA in our patients warrants a closer follow-up with imaging studies, because these patients with positive ctDNA seem to have a higher risk of recurrence. Dr. Jeanny Aragon-Ching: I agree, Neeraj.  Let's round out the bladder cancer discussion with Abstract 4518, which reported the interim results of SURE-02, which is a phase 2 study evaluating neoadjuvant sacituzumab govitecan plus pembrolizumab in cisplatin-ineligible muscle-invasive bladder cancer. Can you tell us more about this abstract, Neeraj? Dr. Neeraj Agarwal: Sure, Jeanny. So, Dr Andrea Necchi presented interim results from the SURE-02 trial. This is a phase 2 study evaluating neoadjuvant sacituzumab govitecan plus pembrolizumab, followed by a response-adapted bladder-sparing treatment and adjuvant pembrolizumab in patients with muscle-invasive bladder cancer.  So, in this interim analysis, 40 patients were treated and 31 patients were evaluable for efficacy. So, the clinical complete response rate was 38.7%. All patients achieving clinical complete response underwent bladder-sparing approach with a repeat TURBT instead of radical cystectomy. Additionally, 51.6% of patients achieved excellent pathologic response with a T stage of 1 or less after neoadjuvant therapy. The treatment was well tolerated, with only 12.9% of patients experiencing grade 3 or higher adverse events without needing dose reduction of sacituzumab. Molecular profiling, interestingly, showed that clinical complete response correlated with luminal and genomically unstable subtypes, while high stromal gene expression was associated with lack of response.  These results suggest that sacituzumab plus pembrolizumab combination has promising activity in this setting, and tolerability, and along with other factors may potentially allow a bladder preservation approach in a substantial number of patients down the line. Dr. Jeanny Aragon-Ching: Yeah, agree with you, Neeraj. And the findings are very provocative and support completing the full trial enrollment and further exploration of this strategy in muscle-invasive bladder cancer in order to improve and provide further bladder-sparing strategies. Dr. Neeraj Agarwal: Agree. So, let's now turn to the kidney cancer, starting with Abstract 4505, the final overall analysis from CheckMate-214 trial, which evaluated nivolumab plus ipilimumab, so dual checkpoint inhibition strategy, versus sunitinib in our patients with metastatic clear cell renal cell carcinoma. Dr. Jeanny Aragon-Ching: Yeah, absolutely, Neeraj. So, the final 9-year analysis of the phase 3 CheckMate-214 trial confirms the long-term superiority of nivolumab and ipilimumab over sunitinib for first-line treatment of advanced metastatic renal cell carcinoma. So, this has a median follow-up of 9 years. Overall survival remains significantly improved with the combination. So, in the ITT patient population, the intention-to-treat, the hazard ratio for overall survival was 0.71. So, this translates to a 29% reduction in the risk of death. 31% of patients were alive at this 108-month follow-up compared to 20% only in those who got sunitinib. So, similar benefits were observed in the intermediate- and poor-risk groups with a hazard ratio of 0.69, and 30% versus 19% survival at 108 months.  Importantly, a delayed benefit was also seen in those favorable-risk patients. So, the hazard ratio for overall survival improved from 1.45 in the initial report and now at 0.8 at 9 years follow-up, with 35% of patients alive at 108 months compared to 22% in those who got sunitinib. Progression-free survival also favored the nivo-ipi arm across all risk groups. At 96 months, the probability of remaining progression-free was about 23% compared to 9% in the sunitinib arm in the ITT patient population, 25% versus 9% in the intermediate- and poor-risk patients, and 13% compared to 11% in the favorable-risk patients. Importantly, at 96 months, 48% of patients in the nivo-ipi responders remained in response compared to just 19% in those who got sunitinib. And in the favorable-risk group, 36% of patients who responded remained in response, although data were not available for sunitinib in this subgroup.  So, this data reinforces the use of nivolumab and ipilimumab as a durable and effective first-line effective strategy for standard of care across all risk groups for advanced renal cell carcinoma. Dr. Neeraj Agarwal: Thank you, Jeanny. And of course, since ipi-nivo data were presented, several other novel ICI-TKI combinations have emerged. And I'm really hoping to see very similar data with TKI-ICI combinations down the line. It is really important to note that we are not seeing any new safety signals with the ICI combinations or ICI-based therapies, which is very reassuring given the extended exposure. Dr. Jeanny Aragon-Ching: Absolutely agree with you there, Neeraj.  Now, going on and moving on to Abstract 4514, which is the KEYNOTE-564 trial, and they reported on the 5-year outcomes of adjuvant pembrolizumab in clear cell RCC in patients who are at high risk for recurrence. Can you tell us a little bit more about this abstract, Neeraj? Dr. Neeraj Agarwal: Sure. So, the KEYNOTE-564 trial established pembrolizumab monotherapy as the first adjuvant regimen to significantly improve both disease-free survival and overall survival compared to placebo after surgery for patients with clear cell renal cell carcinoma. So, Dr Naomi Haas presented the 5-year update from this landmark trial.  A total of 994 patients were randomized to receive either pembrolizumab or placebo. The median follow-up at the time of this analysis was approximately 70 months. Disease-free survival remained significantly improved with pembrolizumab. The median DFS was not reached with pembrolizumab compared to 68.3 months with placebo, with a hazard ratio of 0.71, translating to a 29% reduction in risk of recurrence. At 5 years, 60.9% of patients receiving pembrolizumab remained disease-free compared to 52.2% with placebo. Overall survival also favored pembrolizumab. The hazard ratio for OS was 0.66, translating to a 34% reduction in risk of death, with an estimated 5-year overall survival rate of 87.7% with pembrolizumab compared to 82.3% for placebo. Importantly, these benefits were consistent across all key subgroups, including patients with sarcomatoid features. In addition, no new serious treatment-related adverse events have been reported in the 3 years since treatment completion.  So, these long-term data confirm pembrolizumab as a durable and effective standard adjuvant therapy for patients with resected, high-risk clear cell renal cell carcinoma. Dr. Jeanny Aragon-Ching: Thank you for that wonderful summary, Neeraj. Dr. Neeraj Agarwal: That wraps up our kidney cancer highlights. Any closing thoughts, Jeanny, before we conclude? Dr. Jeanny Aragon-Ching: It's been so wonderful reviewing these abstracts with you, Neeraj. So, the 2025 ASCO Annual Meeting showcased a lot of transformative data across GU cancers, from first-in-class bispecifics to long-term survival in RCC. And these findings are already shaping our clinical practices. Dr. Neeraj Agarwal: I agree. And we have covered a broad spectrum of innovations in GU cancers with strong clinical relevance.  So, thank you, Jeanny, for joining me today and sharing your insights.  And thank you to our listeners for joining us. You will find links to the abstracts discussed today in the transcript of this episode. If you find these conversations valuable, please take a moment to rate, review, and subscribe to the ASCO Daily News Podcast wherever you listen. Thank you so much. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:    Dr. Neeraj Agarwal     @neerajaiims     Dr. Jeanny Aragon-Ching   Follow ASCO on social media:       @ASCO on Twitter       ASCO on Bluesky   ASCO on Facebook       ASCO on LinkedIn       Disclosures:   Dr. Neeraj Agarwal:   Consulting or Advisory Role: Pfizer, Bristol-Myers Squibb, AstraZeneca, Nektar, Lilly, Bayer, Pharmacyclics, Foundation Medicine, Astellas Pharma, Lilly, Exelixis, AstraZeneca, Pfizer, Merck, Novartis, Eisai, Seattle Genetics, EMD Serono, Janssen Oncology, AVEO, Calithera Biosciences, MEI Pharma, Genentech, Astellas Pharma, Foundation Medicine, and Gilead Sciences  Research Funding (Institution): Bayer, Bristol-Myers Squibb, Takeda, Pfizer, Exelixis, Amgen, AstraZeneca, Calithera Biosciences, Celldex, Eisai, Genentech, Immunomedics, Janssen, Merck, Lilly, Nektar, ORIC Pharmaceuticals, Crispr Therapeutics, Arvinas  Dr. Jeanny Aragon-Ching:   Honoraria: Bristol-Myers Squibb, EMD Serono, Astellas Scientific and Medical Affairs Inc., Pfizer/EMD Serono   Consulting or Advisory Role: Algeta/Bayer, Dendreon, AstraZeneca, Janssen Biotech, Sanofi, EMD Serono, MedImmune, Bayer, Merck, Seattle Genetics, Pfizer, Immunomedics, Amgen, AVEO, Pfizer/Myovant, Exelixis,    Speakers' Bureau: Astellas Pharma, Janssen-Ortho, Bristol-Myers Squibb, Astellas/Seattle Genetics

Lorsqu'elle a reçu les clés de son logement, un poids est tombé des épaules d'Angelika Stibi. Cette retraitée allemande dans le besoin ne paiera plus que 88 cents de loyer par mois, dans le plus vieil habitat social du monde,en Bavière.La sexagénaire fait partie depuis le printemps des quelque 150 habitants de la "Fuggerei", une résidence d'Augsbourg, dans le sud de l'Allemagne, dont le loyer n'a pas bougé ... depuis le Moyen-Age.Créés en 1521 par le banquier Jacob Fugger, les plus vieux logements sociaux du monde, selon leurs administrateurs, sont toujours en service et très demandés.Réalisation : Emmanuelle BaillonReportage AFPTV : Olivier FenietDoublages : Camille Buonanno, Emmanuelle Michel, Michaëla Cancela-Kieffer, Sofiane Ouanes, Meïssa Guèye, Luca MatteucciSur le Fil est le podcast quotidien de l'AFP. Vous avez des commentaires ? Ecrivez-nous à podcast@afp.com. Vous pouvez aussi nous envoyer une note vocale par Whatsapp au + 33 6 79 77 38 45. Si vous aimez, abonnez-vous, parlez de nous autour de vous et laissez-nous plein d'étoiles sur votre plateforme de podcasts préférée pour mieux faire connaître notre programme Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Við fræddumst í dag um það sem kallast skeiðakenningin. Höfundur kenningarinnar, Christine Miserando, þróaði þessa kenningu til að geta útskýrt fyrir vinkonum sínum hvernig hún verður að skipuleggja hvern einasta dag og að hún gæti ekki gert allt sem hún vildi, en hún glímdi frá 15 ára aldri við skerðingar á daglegu lífi vegna þreytu og verkja. Guðrún Friðriksdóttir iðjuþjálfi hjá Ljósinu, endurhæfingarmiðstöð fyrir krabbameinsgreinda, vinnur talsvert með skeiðakenninguna í sínu starfi og hún kom í þáttinn og sagði okkur betur frá í dag. Við fengum svo lifandi tónlist um miðbik þáttarins þegar systkinin í hljómsveitinni Blood Harmony komu í viðtal og spiluðu fyrir okkur og sungu, Ösp, Örn Eldjárn, en Björk systir þeirra var fjarri góðu gamni í þetta sinn. Þau hyggja á plötuútgáfu á næsta ári og spila á nokkrum tónleikum í sumar og taka þátt í Sumartónum í Salnum í dag. Þau fluttu í hljóðverinu hjá okkur lagið Draumsnillingar sem Ösp samdi og gaf Erni í jólagjöf. Bergsteinn Sigurðsson, kollegi okkar úr sjónvarpinu, kom við á Minjasafninu á Hnjóti í Örlygshöfn í sunnanverðum Patreksfirði og hitti Sigríði Soffíu Níelsdóttur, danshöfund og listakonu, en hún var þar með uppákomu undir merkjum Eldblóma, sem er hennar vörumerki fyrir hennar list, hvort sem það eru líkjörar, ilmur, flugeldasýning, haustlaukar og blómainnsetning. Bergsteinn var svo góður að leyfa okkur að senda það út í þættinum í dag. Tónlist í þættinum í dag: Spánardraumur / Hljómsveit Ingimars Eydal (erlent lag, texti Einar Haraldsson) Sideways / Sigrún Stella (Sigrún Stella Draumsnillingar / Blood Harmony (Ösp Eldjárn) Tasko Tostada / Hljómar (Rúnar Júlíusson) UMSJÓN GUÐRÚN GUNNARSDÓTTIR OG GUNNAR HANSSON

Gravel Union Talks is a podcast series full of inspiring stories, news and events from the world of gravel biking. Each month hosts Carlo and Olly will be chatting with guests who are passionate about riding off the beaten track… adventure riding, bike packing and gravel racing. In this episode:Kofi KyeiGravel Union Talks podcast with hosts Carlo van Nistelrooy and Olly Townsend.GU's editor-in-chief Olly on last month's most popular articles on the Gravel Union platform.Want to bring in ideas for topics or guests?Mail Olly at info@gravelunion.cc Check out our platform and socialswww.gravelunion.ccInsta: @gravel_unionFacebook: https://www.facebook.com/GravelUnion/Komoot: https://www.komoot.nl/user/1080024447202Thanks for listening. Please share a review, like and share!Don't forget: join us nowGravel Inspiration - Gralloch Gravel, setting the gold standardDespite women making up nearly half the global population, they've long been underrepresented in gravel racing. With more and more women now signing-up to race at the highest levels of the sport you would hope that race organisers would do everything in their power to make the experience for female racers as good as possible, but this hasn't always been the case. Elite racer Caroline Livesey reports back from The Gralloch, an event which is attempting to buck the trend and set the gold standard for women's gravel racing.Gravel Inspiration – Gravel riding with the Nepali cycling queenMost world-class athletes will be supervised by a security team and the closest you could hope to get to them is a rushed autograph at best. Fortunately for us, gravel riding is a different world. Earlier in the year, Olly was fortunate enough to be invited to go and join a group of passionate gravel riders as they participated in the inaugural Trans-Nepal gravel event. The head guide on the trip was  Usha Khanal, who as a former Nepali cross-country and downhill national MTB champion, is as close to cycling royalty as you could hope to meet. Armchair Adventure – Riding the length of AfricaMost of us aspire to do a big ride at some point during our lives as gravel riders.  But everyone's definition of ‘big' differs somewhat. It might be that 100 km or 200 km is as big as you imagine. For Wiebke Lühmann though big is a relative term. During 2024 she rode from her home in Germany down the west coast of Africa to reach the Cape of Good Hope, a total distance of over 20,000 km. We chatted with her recently to find out what makes her tick.

Este es el episodio #114 de “Tradiciones Sabias”, el podcast en español de la Fundación Weston A. Price. Algunos de los temas de este episodio: - Por qué el ser humano es una especie clave para mantener ecosistemas - Qué otras especies juegan un rol clave - Cómo históricamente el ser humano ha mantenido ecosistemas diversos en todo el mundo - Técnicas y herramientas que hemos usado a través de los años Datos Biográficos: Raimundo es Científico de la Universidad Waikato, de Nueva Zelanda. Sus estudios son en Ciencias de la Tierra con Especialización en Suelos, Permacultura, Agricultura Sintrópica y Manejo Holístico. Se dedica a aplicar estos conocimientos en un ex terreno forestal altamente degradado, descubriendo a diario el gran potencial de la Restauración Agroecosistema, realizando Consultorías prediales a lo largo de todo Chile y el mundo. Contacto: - Web: www.yoregenero.org  - Instagram: instagram.com/yo_regenero  Preguntas, comentarios, sugerencias: tradicionessabias@gmail.com      Recursos en español de la Fundación Weston A. Price -   - Página web WAPF en Español: https://www.westonaprice.org/espanol/ - Cuenta de Instagram: westonaprice_espanol - Guía alimentación altamente nutritiva, saludable y placentera:  11 principios dietéticos - Paquete de Materiales GRATIS:  https://secure.westonaprice.org/CVWEBTEST_WESTON/cgi-bin/memberdll.dll/openpage?wrp=customer_new_infopak_es.htm  - Folleto "La Leche Real", de Sally Fallon:  https://www.westonaprice.org/wp-content/uploads/La-leche-real.pdf  Música de Pixabay: Sound Gallery y SOFRA  

¿Eres emprendedora, creadora de contenido o coach y estás lista para tomar  imperfecta acción con tu negocio digital? ¡Este espacio es para ti! 

Depuis le mois de décembre 2024, la Belgique permet aux travailleurs et travailleuses du sexe d'être salariés. C'est le premier pays au monde à donner accès à un tel droit aux personnes en situation de prostitution. Saluée par de nombreuses associations, cette nouvelle loi offre une protection et une sécurité inédite aux travailleurs et travailleuses du sexe en les consiérant comme des salariés comme les autres. Mais la mise en application de cette législation reste compliquée.Sur le fil vous emmène en Belgique, à la rencontre de ces nouveaux salariés avec, sur le terrain, Dimitri Korczak, journaliste reporter d'images à l'AFP.Invités : Thierry Schaffauser, trésorier du Syndicat du Travail Sexuel, en France"Mel", connue sous le pseudo de Meliciousss, travailleuse du sexe et militanteMarianne Chargois, travailleuse du sexe et militante pour l'Union des Travailleur·euses du Sexe, en BelgiqueCharles-Eric Clesse, magistrat belge expert en droit du travail et en matière de traite des êtres humainsCrédits TikTok : @weesliefvoorelkaarmetmel “Mel meliciousss”Réalisation : Camille BuonannoPrésentation : Emmanuelle BaillonDoublages : Meïssa Guèye Sur le Fil est le podcast quotidien de l'AFP. Vous avez des commentaires ? Ecrivez-nous à podcast@afp.com. Vous pouvez aussi nous envoyer une note vocale par Whatsapp au + 33 6 79 77 38 45. Si vous aimez, abonnez-vous, parlez de nous autour de vous et laissez-nous plein d'étoiles sur votre plateforme de podcasts préférée pour mieux faire connaître notre programme. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Brot úr Rauða borðinu 25. júní 2025 Reynsluboltar Ragnheiður Davíðsdóttir, Guðmundur Þ. Ragnarsson og Gunnar Hólmsteinn Ársælsson ræða það sem hæst ber og tala af reynslu. Við komum við á Alþingi og út í heimi. Af nógu er að taka þessa dagana. Það virðist vera langt í hinu árlegu sumargúrku.

Steinþór Helgi og Ásgeir Guðmundsson komu og sögðu frá Innipúkanum. Tríóið Mammaðín kíkti einnig í heimsókn og flutti tvö lög. STUÐMENN - Energí Og Trú. Birnir, GDRN - Sýna mér (ft. GDRN). BOSTON - More Than A Feeling [Single Version]. Bríet - Blood On My Lips. Jungle - Back On 74. Ólafur Bjarki Bogason - Fyrr en varir. ÞÓRUNN ANTONÍA - Too late. Purrkur Pillnikk - Ekki enn. BOGOMIL FONT & FLÍS - Þvo sér hendur. Andreas Odbjerg & Emma Sehested Høeg - Svært at være Fantastisk Sheeran, Ed - Azizam. DUSTY SPRINGFIELD - You Don't Have To Say You Love Me. Meddi Sinn - Love after Death. GALA - Freed from desire. Iommi, Tony, Williams, Robbie - Rocket. Summer, Donna - Love to love you baby. BELLE & SEBASTIAN - Another Sunny Day. GRAFÍK - Presley. BERNDSEN - Supertime. Hjálmar - Ólína og ég. HANNES FT. WATERBABY - Stockholmsvy. MIKA - Relax. Ragga Holm, Júlí Heiðar Halldórsson, Ragnhildur Jónasdóttir - Líður vel. Justin Timberlake - Mirrors. Tríóið Mammaðín - Hné Tríóið Mammaðín -Lúsmý Withers, Bill - Ain't no sunshine. Ásdís - Touch Me. EAGLES - Take it easy. Ellis-Bextor, Sophie - Taste. SUZANNE VEGA - Luka. Una Torfadóttir, CeaseTone - Þurfum ekki neitt. Kaleo - Bloodline. FLEETWOOD MAC - Landslide. Mollý Jökulsdóttir - If I. DEPECHE MODE - Enjoy The Silence. Jóhanna Guðrún Jónsdóttir Söngkona - Þú ert nú meiri. Meddi Sinn - You. GEORGE BAKER SELECTION - Little Green Bag. Amabadama - Gaia Pulp - Got to have Love Lay Low - By and by MIA - Paper Planes Sufjan Stevens - Chicago

Us portem can

Miðvikudagur 25. júní Utanríkisstefna, reynsluboltar, þingmaður, þjóðin, sumartónleikar og aktivismi Við hefjum leik með viðbrögðum formanns utanríkismálanefndar Alþingis við tíðindum dagsins í Haag. Pawel Bartoszek bregst við tíðindum um að langflest NATO-ríki greiða 5 prósent af þjóðarframleiðslu til varnamála og framlög Íslands stóraukast. Helen Ólafsdóttir öryggissérfræðingur gagnrýnir valkyrjur ríkisstjórnarinnar fyrir að bjóða landsmönnum upp á óbreytta utanríkisstefnu þrátt fyrir gerbreytta heimsmynd. Hún segir Gunnari Smára hvað vantar í stefnuna. Ragnheiður Davíðsdóttir, Guðmundur Þ. Ragnarsson og Gunnar Hólmsteinn Ársælsson ræða það sem hæst ber og tala af reynslu við Sigurjón Magnús Egilsson. Af nógu er að taka þessa dagana hvað varðar þjóðmálin og virðist langt í hina árlegu sumargúrku. Eiríkur Björn Björgvinsson er í hópi nýrra þingmanna. Björn Þorláks rekur garnirnar úr Eiríki og leitast við að kynnast persónulegri hlið hans. Skelfilegt flugslys sem reyndi mikið á Eirík er til umræðu og hvaða mælikvarða hann notaði til að velja sér eiginkonu! Og það verður einnig umræða um að þingmenn tali um ykkur og okkur og með því sé sáldrað efasemdum um að veiðigjöldin séu landsbyggðarskattur - til að skapa efasemdir. Jón Trausti Reynisson ritstjóri skrifaði leiðara um þetta og Sigurjón Magnús ræðir við hann. Benedikt Kristjánsson, söngvari og skipuleggjandi hátíðarinnar Sumartónleikar í Skálholti, 28. júní - 13. júlí, segir okkur frá stórkostlegri dagskrá tónleikanna í ár. Hátíðin fagnar 50 ára afmæli og eru haldnir til heiðurs Helgu Ingólfsdóttur og mun Jean Rondeau leika á sembalinn hennar. Benedikt ræðir líka um sjálfboðaliðun menningarinnar, um tengslin við fjármögnunina, um umboðsmenn og eigin söng. Oddný Eir Ævarsdóttir ræðir við hann. Við ljúkum dagskránni með því að Anahita B, aðgerðarsinni frá Íran ræðir um Íran og réttarhöldin gegn Hval hf. Anahita segir frá stríðinu frá sjónarhóli hins almenna Írana, um hvernig þjóðin upplifir sig í raun fasta milli tveggja elda, stríðinu við kúgandi klerka og stríðinu við vesturlönd en báðir aðilar sjá hag sinn í að hefta frelsi og mannhelgi almennings.

We head back in time to discuss the biggest pop culture moments and news from the year 2000!Mac kicks off the episode with the year's superlatives, before Gu breaks out the tiermaker and the gruesome twosome decide what is truly important from the year 2000!Join the conversation... FacebookInstagramTwitterTikTokYouTubeRate/Review/Subscribe:Apple PodcastsSpotifyYouTube

La nanotecnóloga y divulgadora Anna Morales nos habla sobre la ciencia detrás de ficciones como 'Guía del autoestopista galáctico'

En este episodio vamos directos al grano: Guía paso a paso para ganar dinero en bolsa en 2025, sobre todo, en esta segunda mitad, ya que las cosas han cambiado un poco. Qué acciones comprar, por qué... Y mucho más.OFERTA DE VERANO: 15% de Descuento + Suites de formación: Con el código "VERANOBC" en: https://boringcapital.net/contrata

La nanotecnóloga y divulgadora Anna Morales nos habla sobre la ciencia detrás de ficciones como 'Guía del autoestopista galáctico'

Grabamos un podcast a 4500 metros de altura, en la locación donde se filmó la película "El Páramo" en 2011.Segundo capítulo de la serie RODANDO POR EL EJE, donde visitamos algunas de las locaciones que hacen parte de la GUÍA DE TURISMO CINEMATOGRÁFICO desarrollada por el equipo de La Falla Destino Fílmico.Link de Youtube aquíEn este episodio salimos desde Santa Rosa de Cabal hasta la base militar del Cerro El Gualy. Este escenario nos sirvió para hablar de los "destinos silenciosos" en los que se han filmado películas como El Páramo o Memoria. Nuestra invitada es Quinaya Qumir, miembro del equipo de la Falla y una de las investigadoras de la guía. Para consultar la Guía entra a este enlace: https://lafalla.co/rodandoporeleje/Este contenido llega a vos gracias a: El Patrocinio de La Falla Destino Fílmico Nuestra productora Gente queLa producción ejecutiva de Lemaitre ConsultoresEl amor y confianza de nuestros amigos en Patreon (Nataly Valdivieso, Hamilton Casas, Juliana Núñez, Diana Piñeres). Apóyanos como ellos desde 1 dólar.Si quieres pautar en nuestros episodios, patrocinar nuestro proyecto y todos sus productos como  #ElNoti semanal o producir tu pocdast no dudes en escribirnos a info@gentequehacecine.com Nuestra web: https://gentequehacecine.com/ 

Aplica a una asesoría de planificación de inversiones sin costo para diseñar tu estrategia de ahorro e inversión personalizada

Dr. Svala Ísfeld Ólafsdóttir dósent, við lagadeild Háskólans í Reykjavík, kom í þáttinn í dag og sagði frá Ráðstefnu um vernd barna gegn ofbeldi á heimilinu sem hún stóð að í HR í byrjun júní. Ein af frumskyldum hvers samfélags er að vernda yngstu þegnana og þessi ráðstefna var liður í því, enda eru afleiðingar ofbeldis gegn börnum margþættar og alvarlegar. Svala sagði frá því sem á ráðstefnunni kom fram og frá hennar erindi um rannsókn hennar um kynferðisbrot gegn börnum framin innan skjólveggja heimilisins. Kristinn Guðmundsson sér um matreiðsluþættina Soð sem sýndir eru í sjónvarpinu hér á RÚV, hann sagði okkur í dag frá viðburðum sem hann stendur fyrir og kallar Matarsaga Reykjaness í fimm réttum. Einar Sveinbjörnsson kom svo í veðurspjallið á Jónsmessu sem er í dag. Nýtt tungl kviknar á morgun í suðaustri og stórstreymt verður á fimmtudag og Einar sagði okkur meðal annars frá æðarvarpi og góðri dúntekju, hann sagði frá júní sem verið hefur kaldari en maí hingað til. Svo talaði hann um horfurnar framundan hér á landi og mikla hita víða um heim og spár um framhald þeirra. Tónlist í þættinum í dag: Kóngur einn dag / KK og Magnús Eiríksson (Magnús Eiríksson) Barn / Ragnar Bjarnason (Ragnar Bjarnason, texti Steinn Steinarr) Við saman / Hljómar (Gunnar Þórðarson, texti Þorsteinn Eggertsson og Gunnar Þórðarson) Sólskinsdagur / B.G. og Ingibjörg (lagahöfundur ókunnur, texti Jónas Friðrik Guðnason) UMSJÓN GUÐRÚN GUNNARSDÓTTIR OG GUNNAR HANSSON

Brot úr Rauða borðinu 24. júní Niðurlæging þingmanna Stjórnarandstaða Miðflokks, Framsóknarflokks og Sjálfstæðisflokks niðurlægir lýðræðið með orðum sínum og atferli þessa dagana. Þetta segir doktor Haukur Arnþórsson stjórnsýslufræðingur. Hann bregst við þeirri spurningu hvað stjórnarandstaðan á Alþingi sé að pæla þessa dagana við Rauða borðið ásamt framsóknarmanninum Halli Magnússyni, Ástu Guðrúnu Helgadóttur samfylkingarkonu og Birni Leví Gunnarssyni, fyrrum þingmanni pírata. Björn Þorláks stýrir umræðunni.

Það eru níu dagar í fyrsta leik Íslands á Evrópumótinu í Sviss. Guðmundur Aðalsteinn, Magnús Haukur Harðarson og Óskar Smári Haraldsson hita vel upp fyrir Evrópumótið í þætti dagsins af Uppbótartímanum. Hvernig eru andstæðingar Íslands og hverjar eiga vonir okkar og væntingar að vera? Einnig er aðeins talað um Bestu deildina fyrir langa EM-pásu sem er framundan.

Ásmundur Guðni Haraldsson er maður margra hatta. Hann er aðstoðarskólameistari í Brekkubæjarskóla á Akranesi, aðstoðarþjálfari kvennalandsliðsins í knattspyrnu og landsliðsþjálfari Reitaboltalandsliðsins.Við Ási settumst niður og spjölluðum um væntanlegt Evrópumót, hvers vegna honum finnst svo gefandi að starfa með kvennalandsliðinu, liði sem hann hefur unnið með í yfir 100 landsleikjum og fórum yfir ferilinn frá því Guðjón Þórðar og Luka Luka Kostic gáfu honum sénsinn í KR.Ási sagði mér hvernig hann starfaði sem yfirþjálfari yngri flokka Gróttu og Stjörnunnar og við ræddum að sjálfsögðu það afrek sem hann náði er hann fór með Gróttu úr neðstu deild í þá næst efstu. Auðvitað fórum við svo yfir tímann hjá FH!Síðast, en alls ekki síst, fórum við djúpt ofan í reitaboltafræðin. Hvað gerist til dæmis ef þú klobbar tvo leikmenn í einni snertingu? Það er e.t.v. kominn tími til að gefa út nýtt myndband frá reitaboltasambandinu.Njótið

¡Bienvenida a un nuevo episodio de minigreenpod! Aquí te platico porque es importante remojar y dejar en cocción tus leguminosas. También te comparto algunos tips mágicos.¡Dale play! Gracias por ser parte de mi comunidad de escuchas. Encuentra mi libro  "Alguien en casa quiere comida vegetariana. Guía básica para mamá y papá" en Amazon, Kobo, Apple books o en mi tienda online: https://nutriologaexperta.com/tienda/ Si esta información resuena contigo y deseas un acompañamiento uno a  uno, yo puedo ayudarte a mejorar tus hábitos y tu manera de  alimentarte. Suscríbete a la membresía nutrióloga experta aquí: https://nutriologaexperta.com/servicios-costos/ Búscame como Nutrióloga Experta en Facebook, Instagram, Pinterest y suscríbete a mi canal de Youtube, ahí está disponible mucho más material de valor que he creado para ti. Por favor deja tu reseña en Itunes y en Spotify, así me ayudarás a mejorar el contenido de este programa. ¿Te gustaría ser parte de este proyecto? ¿Quisieras escuchar a alguien especial? Escríbenos a leslie@nutriologaexperta.com

Nú er tími útivista og gönguferða, fólkið í landinu reimar á sig gönguskóna og nýtur fegurðar íslenskrar náttúru. Yfirleitt þarf ekki að leita langt yfir skammt til að finna skemmtilegar gönguleiðir, en það getur þó verið erfitt að vita hvar skal byrja og hvar þær er að finna. Jónas Guðmundsson, gönguleiðsögumaður, landvörður og ferðamálafræðingur hefur varið ótal stundum á fjöllum og á göngu um náttúru landsins og nú hefur hann gefið út nýja bók, Gönguleiðir á höfuðborgarsvæðinu, þar sem hann fjallar um 30 gönguleiðir einmitt á höfuðborgarsvæðinu og nágrenni. Jónas kom í þáttinn í dag og sagði okkur betur frá þessum leiðum og bókinni. Sumartónleikar í Skálholti hafa verið starfandi frá árinu 1975 og staðið fyrir tónleikahaldi í Skálholtskirkju á hverju sumri síðan. Hátíðin er sú elsta og jafnframt stærst sinnar tegundar á landinu og einn stærsti menningarviðburður sem fram fer á Suðurlandi yfir sumartímann. Benedikt Kristjánsson söngvari sagði betur frá hátíðinni í þættinum. Lesandi vikunnar í Mannlega þættinum í þetta sinn var Sigrún Blöndal, kennari og deildarstjóri. Hún sagði okkur frá því hvaða bækur hún hefur verið að lesa undanfarið og hvaða bækur og höfundar hafa haft mest áhrif á hana í gegnum tíðina. Sigrún sagði frá eftirfarandi bókum og höfundum: Ann Cleves og Shetland seríu hennar og sögupersónunni Veru Stanhope. Lee Child og bækurnar um Jack Reacher Stig Larsson og bækurnar um Lisbeth Salander Det forsömte forår e. Hans Scherfig Fornaldarsögur Norðurlanda Hrólfssaga Kraka Tónlist í þættinum í dag: Sól mín sól / Anna Pálína Árnadóttir (Aðalsteinn Ásberg Sigurðsson) Styttur bæjarins / Spilverk þjóðanna (Egill Ólafsson, Valgeir Guðjónsson og Sigurður Bjóla Garðarsson) Don't Stop Me Now / Philharmonix (Freddie Mercury) UMSJÓN GUÐRÚN GUNNARSDÓTTIR OG GUNNAR HANSSON

Rencontres au sommet, à l'occasion du Chamonix Film Festival, autour de la montagne, un terrain de jeux et d'enjeux pour les grimpeurs et passionnés du monde entier. Connue pour être la capitale mondiale de l'alpinisme, la ville de Chamonix a accueilli pour la cinquième année le Chamonix Film Festival, qui s'est tenu à la mi-juin au pied du Mont-Blanc, plus haut sommet d'Europe et point culminant des Alpes, réunissant passionné.e.s de montagne et d'aventure : réalisateurs-réalisatrices, alpinistes et grimpeurs-grimpeuses de tous bords.   En 2019, l'alpinisme a été classé au patrimoine culturel immatériel de l'humanité par l'Unesco ; car la montagne est une culture à part entière, un monde d'altitude, de neige et de roche où la manière de se mouvoir, d'appréhender son environnement, de vivre, écrire les éléments sont singuliers, à part. Les figures historiques, les pionniers passés par Chamonix, y ont laissé des traces et transmis des valeurs propres à la montagne. Terrain de jeu des alpinistes, la montagne est aussi un terrain d'enjeux sociétaux, économiques ou environnementaux, à commencer par le réchauffement climatique. En haute montagne, parmi des glaciers qui reculent et des roches qui s'effondrent, la hausse des températures est encore plus significative qu'en contrebas et elle se vit au quotidien. De plus en plus de récits, de films et de grimpeurs s'emparent d'ailleurs de cette question, conscients que la montagne est fragile et en première ligne.  Autre enjeu : l'accès aux sommets. En effet, depuis que l'alpinisme ou les sports d'hiver se sont développés dans les Alpes ou ailleurs, force est de constater que la montagne est devenue un espace de privilèges, masculin souvent, de blanchité aussi, un domaine d'altitude réservé à ceux qui ont les moyens de l'arpenter, de s'y projeter. Mais des passionné.e.s cherchent à la partager, perpétuant ainsi cet idéal, né à l'après-guerre en France, d'une montagne pour tous et toutes.  Car les gens de montagne le savent, pour y avoir grandi ou s'y être trouvé : la montagne fait du bien ; elle est un environnement précieux, un refuge naturel qui soigne le corps et l'âme, loin du fracas du monde.  Avec : La grimpeuse et ex-championne d'escalade Liv Sansoz, qui a notamment achevé, en 2018, son rêve de gravir les 82 sommets des Alpes de plus de 4 000 mètres. Récemment, elle s'est envolée du deuxième plus haut sommet du monde, le K2, en parapente biplace L'alpiniste prodige Benjamin Védrines, âgé de 32 ans, qui affiche un palmarès insolent de premières en montagne, comme à l'été 2024 avec le record d'ascension du K2 sans oxygène ou, plus récemment, la première ascension en solo et en hiver de la voie BASE des Drus Le réalisateur français et fondateur du Chamonix Film Festival Christophe Raylat. À lire aussiAlpinisme : la prouesse de Liv Sansoz qui a gravi le K2 sans oxygène et en duo En savoir plus : Sur le Chamonix Film Festival qui s'est tenu à la mi-juin à Chamonix Sur Chamonix, capitale mondiale de l'alpinisme Sur Benjamin Védrines, le champion français de la grimpe et parrain du Festival Sur Liv Sansoz et son film K2 mon amour, prix du Public au Chamonix Film Festival Sur les Éditions Guérin, basées à Chamonix, qui publient, depuis 30 ans, récits de montagne et d'alpinisme.  À écouter aussiAlpinisme: la voie des cimes    

LAUDES SÁBADO DE LA XI SEMANA DEL TIEMPO ORDINARIO(Oración de la mañana) - IV Salterio*Link de apoyo al canal al final del escrito*INVOCACIÓN INICIALV. Señor abre mis labiosR. Y mi boca proclamará tu alabanzaINVITATORIOAnt. Escuchemos la voz del Señor y entremos en su descanso.SALMODIASalmo 91 - Ant.Es bueno tocar para tu nombre, oh Altísimo, y proclamar por la mañana tu misericordia.Cántico - Ant. Os daré un corazón nuevo y os infundiré un espíritu nuevo.Salmo 8 - Ant. De la boca de los niños de pecho, Señor, has sacado una alabanzaCÁNTICO EVANGÉLICOAnt. Guía nuestros pasos, Dios de Israel, por el camino de la paz.Cántico de Zacarías. EL MESÍAS Y SU PRECURSOR      Lc 1, 68-79Bendito sea el Señor, Dios de Israel,porque ha visitado y redimido a su pueblo.suscitándonos una fuerza de salvaciónen la casa de David, su siervo,según lo había predicho desde antiguopor boca de sus santos profetas:Es la salvación que nos libra de nuestros enemigosy de la mano de todos los que nos odian;ha realizado así la misericordia que tuvo con nuestros padres,recordando su santa alianzay el juramento que juró a nuestro padre Abraham.Para concedernos que, libres de temor,arrancados de la mano de los enemigos,le sirvamos con santidad y justicia,en su presencia, todos nuestros días.Y a ti, niño, te llamarán Profeta del Altísimo,porque irás delante del Señora preparar sus caminos,anunciando a su pueblo la salvación,el perdón de sus pecados.Por la entrañable misericordia de nuestro Dios,nos visitará el sol que nace de lo alto,para iluminar a los que viven en tinieblay en sombra de muerte,para guiar nuestros pasospor el camino de la paz.Gloria al Padre, y al Hijo, y al Espíritu Santo.Como era en el principio, ahora y siempre, por los siglos de los siglos. Amén.PRECES“Escúchanos, Señor. ”Conclusion. El Señor nos bendiga, nos guarde de todo mal y nos lleve a la vida eterna.R. Amén.(364)

Guía para afrontar un ataque de pánico Un ataque de pánico puede sentirse como perder el control por completo: el corazón se acelera, la respiración se bloquea, la mente se llena de miedo. Pero no estás solo/a y no estás en peligro, aunque lo parezca. En este episodio te ofrezco una guía clara, práctica y emocionalmente contenida para reconocer los síntomas, entender lo que está ocurriendo y aplicar herramientas efectivas para atravesarlo con más calma y seguridad. 💛 Respira. Estás aquí. Puedes con esto. 📲 Escúchalo ahora en iVoox, Spotify o en 🌐 psicologoemocionalonline.com #AtaqueDePánico #Ansiedad #SaludMental #PsicólogoEmocionalOnline #TerapiaOnline #GuíaEmocional #CrisisDeAnsiedad #Respira #NoEstásSolo #PodcastPsicología #GestiónEmocional

Daydreaming of registering for a marathon or in the thick of training? Wherever you fall on the marathon-spectrum (including “no way, no how!”), you'll enjoy this episode. Hosts Sarah Bowen Shea and Coach Liz Waterstraat talk to four “regular” runners about their debut marathon pursuits. They cover topics such as: -their marathon motivations; -the satisfaction of setting and striving toward a goal; -how the run/walk method makes 26.2 attainable; -the “delicious pain” that comes with covering the miles; and, -the mountain of laundry generated during training! Before the first marathoner joins around 10:38, the hosts share about their first marathons—and Chicagoland's “garbage hills!” Register for our Lake Placid retreat.  When you shop our sponsors, you help AMR. We appreciate your—and their—support! GU for it: Get 20% off with code AMR2520 at GUenergy.com thru 6/30/25  Use code INF-AMR to get a gift card good for your next purchase at Selkirk.com  Get 20% off, plus free shipping, on allIQBAR products by texting AMR to 64-000 Learn more about your ad choices. Visit megaphone.fm/adchoices

www.patreon.com/skodanabraedurStyrktaraðilar þáttarins: Myntkaup, Silkisvefn, World Class, Gæði & Takk takk (15% afsláttur á takktakk.is með kóðanum SB15).Það sem snert er á: Íslenskt sjálfstæði, menntakerfið, stjórnarskráin, Napóleon, Bitcoin, Jordan Peterson, bókun 35, Hans Herman-Hoppe, 19. öld, afnám velferðarkerfis og Guð.

¿Te ha pasado que mejoras económicamente… pero de repente todo vuelve a su punto inicial? No es casualidad. Es tu termostato financiero inconsciente saboteando tu avance. En este episodio te explico, con base real y estrategias prácticas, por qué la mayoría no logra sostener la riqueza que genera —y qué hacer para reprogramar tu sistema mental y emocional para que la abundancia se vuelva tu estado natural. Nada de fórmulas mágicas ni misticismo. Te hablo de lo que realmente hace la diferencia: ✅ Cómo identificar tu termostato financiero oculto ✅ El rol de tu lenguaje interno en la creación de riqueza ✅ Por qué competir te mantiene en escasez (y cómo empezar a crear) ✅ La diferencia entre perseguir dinero y permitir que fluya ✅ Cómo sostener emocionalmente más riqueza sin sabotearla ✅ El principio que distingue a quienes construyen abundancia real Además, te comparto una herramienta clave para trabajar la raíz de todo esto: tu disciplina emocional. Descarga ahora la Guía gratuita de Disciplina Emocional aquí: https://recursos.conocimientoexperto.com/guiadisciplinaemocional Recuerda: no atraes lo que deseas. Atraes lo que eres capaz de sostener. Sígueme y accede a más contenido: Web: https://conocimientoexperto.com/ Instagram: https://www.instagram.com/salvadormingo/ Podcast: https://open.spotify.com/show/65J8RTsruRXBxeQElVmU0b Guías: https://conocimientoexperto.com/accede-a-las-guias LinkedIn: https://www.linkedin.com/in/salvadormingoce/ YouTube: https://www.youtube.com/@UC80Q7vyU9ZMfePxogSdb8kA Nos vemos dentro del episodio. Salvador Mingo Creador de Conocimiento Experto Especialista en estrategia, contenido digital y transformación personal

¿Te ha pasado que mejoras económicamente… pero de repente todo vuelve a su punto inicial? No es casualidad. Es tu termostato financiero inconsciente saboteando tu avance. En este episodio te explico, con base real y estrategias prácticas, por qué la mayoría no logra sostener la riqueza que genera —y qué hacer para reprogramar tu sistema mental y emocional para que la abundancia se vuelva tu estado natural. Nada de fórmulas mágicas ni misticismo. Te hablo de lo que realmente hace la diferencia: ✅ Cómo identificar tu termostato financiero oculto ✅ El rol de tu lenguaje interno en la creación de riqueza ✅ Por qué competir te mantiene en escasez (y cómo empezar a crear) ✅ La diferencia entre perseguir dinero y permitir que fluya ✅ Cómo sostener emocionalmente más riqueza sin sabotearla ✅ El principio que distingue a quienes construyen abundancia real Además, te comparto una herramienta clave para trabajar la raíz de todo esto: tu disciplina emocional. Descarga ahora la Guía gratuita de Disciplina Emocional aquí: https://recursos.conocimientoexperto.com/guiadisciplinaemocional Recuerda: no atraes lo que deseas. Atraes lo que eres capaz de sostener. Sígueme y accede a más contenido: Web: https://conocimientoexperto.com/ Instagram: https://www.instagram.com/salvadormingo/ Podcast: https://open.spotify.com/show/65J8RTsruRXBxeQElVmU0b Guías: https://conocimientoexperto.com/accede-a-las-guias LinkedIn: https://www.linkedin.com/in/salvadormingoce/ YouTube: https://www.youtube.com/@UC80Q7vyU9ZMfePxogSdb8kA Nos vemos dentro del episodio. Salvador Mingo Creador de Conocimiento Experto Especialista en estrategia, contenido digital y transformación personalConviértete en un seguidor de este podcast: https://www.spreaker.com/podcast/conocimiento-experto--2975003/support.

Primer capítulo de la serie RODANDO POR EL EJE, donde visitamos algunas de las locaciones que hacen parte de la GUÍA DE TURISMO CINEMATOGRÁFICO desarrollada por el equipo de La Falla Destino Fílmico.PARA VERLO EN YOUTUBE AQUÍEn este episodio salimos desde Pereira hasta Santa Rosa de Cabal y hablamos de los "destinos de añoranza" aquellos en los que recordamos películas como Milagro en Roma y Café con Aroma de Mujer. Nuestro invitado es Juan Carlos Martínez, miembro del equipo de la Falla y uno de los escritores de la guía.Para consultar la Guía entra a este enlace: https://lafalla.co/rodandoporeleje/ Este contenido llega a vos gracias a: El Patrocinio de La Falla Destino Fílmico Nuestra productora Gente queLa producción ejecutiva de Lemaitre ConsultoresEl amor y confianza de nuestros amigos en Patreon (Nataly Valdivieso, Hamilton Casas, Juliana Núñez, Diana Piñeres). Apóyanos como ellos desde 1 dólar.Si quieres pautar en nuestros episodios, patrocinar nuestro proyecto y todos sus productos como  #ElNoti semanal o producir tu pocdast no dudes en escribirnos a info@gentequehacecine.com Nuestra web: https://gentequehacecine.com/ 

Los audios y mensajes que estamos conociendo relacionados con la última trama de corrupción política vinculada a Santos Cerdán, Koldo García y José Luis Ábalos en el Ministerio de Transportes, hablan de sobornos, de comisiones y también de prostitución, un elemento que parece formar parte del paisaje macho de la corrupción política y personal. Es una práctica a la que se acude o se comenta en grupo, que cohesiona relaciones y es también una exhibición de poder, incluso una celebración del éxito, y una confidencia que une para siempre a los hombres. Desde el caso Gürtel al caso Mediador, pasando por un directivo de una fundación pública andaluza, repasamos varios casos de corrupción de los últimos años en los que aparece este ingrediente. Hablamos con Marcos Pinheiro, jefe de Política de elDiario.es, Jennifer Jiménez, periodista de Canarias Ahora y Dani Cela, de elDiario.es en Andalucía. Con Ana Requena, redactora jefa de Género, abordamos este fenómeno desde una óptica feminista y sacamos algunas conclusiones sobre la misoginia que entrañan estos comportamientos. *** Envíanos una nota de voz por Whatsapp contándonos alguna historia que conozcas o algún sonido que tengas cerca y que te llame la atención. Lo importante es que sea algo que tenga que ver contigo. Guárdanos en la agenda como “Un tema Al día”. El número es el 699 518 743See omnystudio.com/listener for privacy information.

Guðmundur Fertram Sigurjónsson og Heiðar Guðjónsson ræða um mikilvægi verðmætasköpunar, um þau áhrif sem of miklir skattar hafa á atvinnulífið, hvort það sé í verkahring stjórnvalda að móta atvinnustefnu, störfin sem verða óvænt til, hvernig íslenska hagkerfið getur litið út í framtíðinni og margt fleira í þessum innihaldsríka þætti.

Cuando pensamos en animales trabajadores, solemos visualizar animales de carga, y entre ellos, por ejemplo, los coches de caballos, una atracción turística en varias ciudades españolas donde apenas existe regulación pensada en el bienestar de los equinos. Si el ser humano le ha puesto límites a su propia explotación laboral, es hora de ir pensando en los límites de los animales que seguimos explotando. En el episodio de hoy nos paramos en Sevilla, con Carmen Ibáñez, productora de este podcast; en Málaga, con Néstor Cenizo, periodista de elDiario.es en Andalucía; y en Palma, con Angy Galvín, directora de elDiario.es en Illes Balears, para hablar de cómo está regulados los coches de caballos en estas ciudades. Con José María Perez Monguió, catedrático de Derecho en la Universidad de Cádiz y estudioso de los derechos de los animales, reflexionamos sobre el trato que la legislación le da a otras especies. *** Envíanos una nota de voz por Whatsapp contándonos alguna historia que conozcas o algún sonido que tengas cerca y que te llame la atención. Lo importante es que sea algo que tenga que ver contigo. Guárdanos en la agenda como “Un tema Al día”. El número es el 699 518 743See omnystudio.com/listener for privacy information.

Este es el episodio #113 de “Tradiciones Sabias”, el podcast en español de la Fundación Weston A. Price. Algunos de los temas de este episodio: - Cuáles son los cortes de carne más cotizados y cuáles nos brindan mayor valor nutricional - Recetas para el aprovechamiento de partes poco utilizadas - Subproductos que podemos aprovechar al consumir el animal entero - Beneficios ambientales y económicos de los productos de origen animal - Valor nutricional de partes menos consumidas, como el tuétano, el tejido conectivo y la sangre Datos Biográficos: Galia es mexicana y es fundadora de La Cocina de Galia, una marca de alimentos funcionales, como el caldo de huesos, los fermentos y otros productos basados en los principios de las dietas ancestrales.  Está certificada por el Instituto de Nutrición Integrativa de Nueva York y es representante en Ciudad de México de la Fundación Weston A. Price.  Contacto: -IG: lacocinadegalia y babylovesfood.mx -Página web: babylovesfood.com Preguntas, comentarios, sugerencias: tradicionessabias@gmail.com      Recursos en español de la Fundación Weston A. Price -   - Página web WAPF en Español: https://www.westonaprice.org/espanol/ - Cuenta de Instagram: westonaprice_espanol - Guía alimentación altamente nutritiva, saludable y placentera:  11 principios dietéticos - Paquete de Materiales GRATIS:  https://secure.westonaprice.org/CVWEBTEST_WESTON/cgi-bin/memberdll.dll/openpage?wrp=customer_new_infopak_es.htm  - Folleto "La Leche Real", de Sally Fallon:  https://www.westonaprice.org/wp-content/uploads/La-leche-real.pdf  Música de Pixabay: Sound Gallery y SOFRA

¿Y si el secreto para multiplicar tu dinero no estuviera en trabajar más... sino en pensar diferente? En este ensayo revelador descubrirás cómo la mente entrenada, la actitud interna y el uso consciente del tiempo son más poderosos que cualquier estrategia financiera tradicional. Inspirado en las enseñanzas de Orison Swett Marden y respaldado por neurociencia, consciencia y principios espirituales, este contenido te dará una nueva perspectiva sobre lo que realmente genera riqueza. No es motivación vacía. Es entrenamiento mental real para activar tu banco invisible y convertirte en un multiplicador nato. Y si comentas "Quiero la guía", te comparto GRATIS una guía de implementación detallada para empezar a salir del bloqueo. DESCARGA LA GUÍA GRATUITA “Cómo Superar tu Bloqueo Energético” https://recursos.conocimientoexperto.com/guiabloqueo SÍGUEME Y CONECTA CON MÁS CONTENIDO: Sitio web: https://conocimientoexperto.com/ Instagram: https://www.instagram.com/salvadormingo/ Podcast: https://open.spotify.com/show/65J8RTsruRXBxeQElVmU0b?si=ecefc81f2172453f ▶️ YouTube: https://www.youtube.com/@conocimientoexperto LinkedIn: https://www.linkedin.com/in/salvadormingoce/ Guías de implementación: https://conocimientoexperto.com/accede-a-las-guias Salvador Mingo Creador de Conocimiento Experto Estratega en desarrollo personal, negocios y transformación interior #DineroYConciencia #MentalidadMillonaria #ConocimientoExperto #RiquezaReal #MultiplicaTuDinero #DesbloqueoEnergético #SalvadorMingo

¿Eres emprendedora, creadora de contenido o coach y estás lista para tomar  imperfecta acción con tu negocio digital? ¡Este espacio es para ti! 

Það var nóg að ræða í Uppbótartímanum, hlaðvarpi um kvennaboltann á Íslandi, í dag. EM hópurinn var valinn síðasta föstudag og ljóst er hvaða 23 leikmenn verða fulltrúar Íslands á EM í Sviss. Hvaða leikmenn eru svekktastir með valið? Þá hefur Besta deildin ekki verið eins skemmtileg í mörg ár. Þrjú lið eru jöfn á toppnum og risi er í veseni. Guðmundur Aðalsteinn og Magnús Haukur fóru yfir sviðið en einnig var aðeins snert á Lengjudeildinni og 2. deild í þættinum.

¿Y si el secreto para multiplicar tu dinero no estuviera en trabajar más... sino en pensar diferente? En este ensayo revelador descubrirás cómo la mente entrenada, la actitud interna y el uso consciente del tiempo son más poderosos que cualquier estrategia financiera tradicional. Inspirado en las enseñanzas de Orison Swett Marden y respaldado por neurociencia, consciencia y principios espirituales, este contenido te dará una nueva perspectiva sobre lo que realmente genera riqueza. No es motivación vacía. Es entrenamiento mental real para activar tu banco invisible y convertirte en un multiplicador nato. Y si comentas "Quiero la guía", te comparto GRATIS una guía de implementación detallada para empezar a salir del bloqueo. DESCARGA LA GUÍA GRATUITA “Cómo Superar tu Bloqueo Energético” https://recursos.conocimientoexperto.com/guiabloqueo SÍGUEME Y CONECTA CON MÁS CONTENIDO: Sitio web: https://conocimientoexperto.com/ Instagram: https://www.instagram.com/salvadormingo/ Podcast: https://open.spotify.com/show/65J8RTsruRXBxeQElVmU0b?si=ecefc81f2172453f ▶️ YouTube: https://www.youtube.com/@conocimientoexperto LinkedIn: https://www.linkedin.com/in/salvadormingoce/ Guías de implementación: https://conocimientoexperto.com/accede-a-las-guias Salvador Mingo Creador de Conocimiento Experto Estratega en desarrollo personal, negocios y transformación interior #DineroYConciencia #MentalidadMillonaria #ConocimientoExperto #RiquezaReal #MultiplicaTuDinero #DesbloqueoEnergético #SalvadorMingoConviértete en un seguidor de este podcast: https://www.spreaker.com/podcast/conocimiento-experto--2975003/support.

Charlamos con Antonio Cancela, el mayor experto de nuestro país en la Guía Michelin. Nos preguntamos junto a Ángel García Muñoz cuándo cortar el habano, ¿antes o después de encenderlo? Viajamos a Logroño para descubrir Wine Fandango, un espacio moderno, vibrante y lleno de vida. Pedro Merino nos comparte sus sensaciones en la degustación de Quai d'Orsay No. 54, una experiencia llena de matices. En los Planes, nos adentramos en el Museo Banksy Madrid, y finalizamos el episodio con la música envolvente de Bell, Book and Candle.

El activismo sigue moviéndose para mostrar, de una manera u otra, el genocidio en Gaza. Por ejemplo: una marcha de 4000 personas de 54 países, desde Egipto a la frontera con Gaza, al paso de Rafah que lleva cerrado más de un año y por la que no se está permitiendo que entre comida a la Franja. Miles de personas partieron hacia Gaza el viernes pasado, aunque la mayoría ya han vuelto porque los mandatarios egipcios no han permitido que la marcha prospere con normalidad. Entre los participantes hay representantes políticos del Congreso de los diputados, de Esquerra Republicana de Catalunya o de Podemos. También de Sumar, como la diputada Tesh Sidi, que nos ha estado mandando notas de voz desde Egipto hasta su regreso a España. Con la periodista de elDiario.es Francesca Cicardi, que estuvo 14 años viviendo en Egipto, intentamos poner contexto a todo lo que nos ha ido contando Tesh Sidi. Además, con Sergio Toribio, que participó en otra acción de visibilidad para Gaza, la Flotilla de la libertad, hablamos del asalto y retención que vivieron por parte de Israel. *** Envíanos una nota de voz por Whatsapp contándonos alguna historia que conozcas o algún sonido que tengas cerca y que te llame la atención. Lo importante es que sea algo que tenga que ver contigo. Guárdanos en la agenda como “Un tema Al día”. El número es el 699 518 743See omnystudio.com/listener for privacy information.

[MÉTAMORPHOSE PODCAST] Anne Ghesquière reçoit Gwénaëlle Persiaux, psychologue, spécialisée en psychotraumatologie. Pourquoi réagissons-nous si fort dans certaines situations ? Comment repérer les manifestations silencieuses d'un trauma ancien ? Comment activer en nous cette part sécure qui nous permet de retrouver l'apaisement, ici et maintenant ? Gwénaëlle Persiaux explore avec clarté les effets visibles et invisibles des psychotraumatismes et ce que chacun peut faire pour s'en libérer. Son ouvrage, Les psychotraumatismes 100 % illustré, coécrit avec Yoanna Micoud et illustré par Johanna Crainmark, est paru chez Eyrolles. Épisode #601Quelques citations du podcast avec Gwénaëlle Persiaux :"Un contexte, qui a été fait de négligence, de manque, d'absence, peut être un psychotraumatisme plus tard en termes de conséquences.""Ce qui fait la différence, c'est la présence ou la solitude au moment du trauma et après.""Un parent qui est sécure, qui vit quelque chose de très difficile, il peut arriver à préserver son enfant."Thèmes abordés lors du podcast avec Gwénaëlle Persiaux :00:00 Introduction03:37 Qu'est-ce qu'un psychotraumatisme ?05:29 Les idées reçues sur le trauma06:33 Les signes qui doivent alerter09:31 Le modèle biopsychosocial11:42 Y a-t-il un risque à trop psychologiser la société ?16:21 L'importance du soutien extérieur18:09 L'importance d'un attachement sécure20:03 Typologie des psychotraumas25:53 Les traumas de négligence27:31 Faut-il revenir sur le passé ?31:04 La dissociation36:01 L'amnésie traumatique42:00 Faut-il forcément chercher la levée de trauma ?43:49 Les traumas vicariants46:03 Comment reconnaître les faux souvenirs ?48:32 Les outils thérapeutiques50:50 Le rôle du mental01:00:18 Peut-on échapper aux faux selfs ?01:03:36 Les crises de milieu de vie01:07:21 La meilleure des boussoles01:08:33 La théorie polyvagale01:09:48 L'exercice 5, 4, 3, 2, 101:11:28 Des exercices en psychologie énergétique01:12:55 Guérison et croissance post traumatiqueÀ réécouter :#365 Traverser la perte de sens #298 Coupé des autres, coupé de soi ! #230 Guérir des blessures d'attachementAvant-propos et précautions à l'écoute du podcast Découvrez Objectif Métamorphose, notre programme en 12 étapes pour partir à la rencontre de soi-même.Recevez un mercredi sur deux la newsletter Métamorphose avec des infos inédites sur le podcast et les inspirations d'AnneFaites le TEST gratuit de La Roue Métamorphose avec 9 piliers de votre vie !Suivez nos RS : Insta, Facebook & TikTokAbonnez-vous sur Apple Podcast / Spotify / Deezer / CastBox/ YoutubeSoutenez Métamorphose en rejoignant la Tribu MétamorphosePhoto DR Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

So it's come to this... A Mac & Gu clip show? Kind of?  Here's a 4-pack of 6-packs to get you ready for the summer!Best Summer DrinksBest Freeze Pop FlavorsBest Rom-Coms (In honor of The Materialists)Best Fictional WhalesJoin the conversation on social media - @MACandGUpodcast

Though Guðmund the Powerful has been laid to rest, tensions between the Möðruvellings and the Ljósvetnings continue into the next generation. In a bold move toward peace, Eyjólf Guðmundarson (the new leader of the Möðruvellings) attempts to create peace by forming an alliance with Þorvarð Hóskuldsson (grandson of Þorgeir Lawspeaker and leader of the Ljósvetnings). But there's a dark cloud on the horizon.  A surprise pregnancy, questions of paternity, and a contested ordeal plunge the region into renewed chaos. As a result, Eyjólf soon finds himself defending his honor in an epic battle against Þorvarð and some pretty overwhelming numbers. Will he do his father proud and claim victory? Or will he lose more than just reputation in the fight? And do we even want Eyjólf to come out on top here? Join us for the most exciting and action-packed episode of this series. Along the way, we explore the finer points of trial by ordeal and medieval Icelandic paternity tests as well. There's so much content here, your head will be spinning!!! Listen and share your thoughts on our social media: Sagathingpodcast on Facebook Sagathingpodcast on Instagram Sagathingpodcast on Bluesky Saga Thing's unofficial official Discord Music Credits Intro Music - "Prelude and Action" by Kevin MacLeod Licensed under Creative Commons: By Attribution 4.0 License http://creativecommons.org/licenses/by/4.0/ Outro Music - "Stormfront" by Kevin MacLeod Licensed under Creative Commons: By Attribution 4.0 License http://creativecommons.org/licenses/by/4.0/